| scholarly article | Q13442814 |
| P2093 | author name string | Øystein Bruserud | |
| Elise Aasebø | |||
| Frode Selheim | |||
| Maria Hernandez-Valladares | |||
| Frode S Berven | |||
| Håkon Reikvam | |||
| Kristin Paulsen Rye | |||
| Kimberley Joanne Hatfield | |||
| Ina Nepstad | |||
| Ida Sofie Grønningsæter | |||
| Karen Marie Hagen | |||
| P2860 | cites work | The role of insulin and IGF system in pancreatic cancer | Q26992015 |
| The Complexity of Targeting PI3K-Akt-mTOR Signalling in Human Acute Myeloid Leukaemia: The Importance of Leukemic Cell Heterogeneity, Neighbouring Mesenchymal Stem Cells and Immunocompetent Cells | Q28074203 | ||
| Universal sample preparation method for proteome analysis | Q29615662 | ||
| Genome-wide methylation profiling in decitabine-treated patients with acute myeloid leukemia | Q30449092 | ||
| Phase I clinical trial of lenalidomide in combination with temsirolimus in patients with advanced cancer | Q33410022 | ||
| Outcomes in patients with relapsed or refractory multiple myeloma in a phase I study of everolimus in combination with lenalidomide | Q33414827 | ||
| Targeting the PI3K/AKT/mTOR signaling network in acute myelogenous leukemia | Q33493174 | ||
| Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis | Q33623036 | ||
| The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients. | Q34024558 | ||
| Renal cortical hexokinase and pentose phosphate pathway activation through the EGFR/Akt signaling pathway in endotoxin-induced acute kidney injury | Q34062861 | ||
| New strategies in the treatment of acute myelogenous leukemia (AML): in vitro culture of aml cells--the present use in experimental studies and the possible importance for future therapeutic approaches. | Q34157180 | ||
| Analysis of acute myelogenous leukemia: preparation of samples for genomic and proteomic analyses | Q34787226 | ||
| Insulin Signaling in Insulin Resistance States and Cancer: A Modeling Analysis. | Q36009767 | ||
| Insulin-InsR signaling drives multipotent progenitor differentiation toward lymphoid lineages | Q36384125 | ||
| Human AML colony growth in serum-free culture | Q36435696 | ||
| CXXC5 (retinoid-inducible nuclear factor, RINF) is a potential therapeutic target in high-risk human acute myeloid leukemia | Q37299309 | ||
| Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel | Q37624593 | ||
| Inputs and outputs of insulin receptor | Q37666434 | ||
| Regulation of cancer metabolism by oncogenes and tumor suppressors | Q38214982 | ||
| Targeting of cell metabolism in human acute myeloid leukemia--more than targeting of isocitrate dehydrogenase mutations and PI3K/AKT/mTOR signaling? | Q38606849 | ||
| Freezing effects on the acute myeloid leukemia cell proteome and phosphoproteome revealed using optimal quantitative workflows | Q38876979 | ||
| Metabolic Reprogramming by the PI3K-Akt-mTOR Pathway in Cancer. | Q38936250 | ||
| A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value. | Q38976994 | ||
| Selecting Sample Preparation Workflows for Mass Spectrometry-Based Proteomic and Phosphoproteomic Analysis of Patient Samples with Acute Myeloid Leukemia | Q39156071 | ||
| Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathway | Q40117414 | ||
| The insulin-like growth factor system in regulation of normal and malignant hematopoiesis | Q40400669 | ||
| A combination of catalase and trehalose as additives to conventional freezing medium results in improved cryoprotection of human hematopoietic cells with reference to in vitro migration and adhesion properties | Q40437077 | ||
| Disease-stabilizing treatment based on all-trans retinoic acid and valproic acid in acute myeloid leukemia - identification of responders by gene expression profiling of pretreatment leukemic cells | Q41625772 | ||
| Reliable FASP-based procedures for optimal quantitative proteomic and phosphoproteomic analysis on samples from acute myeloid leukemia patients. | Q41826496 | ||
| Insulin receptor compensates for IGF1R inhibition and directly induces mitogenic activity in prostate cancer cells | Q41985108 | ||
| Antileukaemic effect of PI3K-mTOR inhibitors in acute myeloid leukaemia-gene expression profiles reveal CDC25B expression as determinate of pharmacological effect | Q43461214 | ||
| Flt3-mediated signaling in human acute myelogenous leukemia (AML) blasts: a functional characterization of Flt3-ligand effects in AML cell populations with and without genetic Flt3 abnormalities. | Q44394415 | ||
| IsobariQ: software for isobaric quantitative proteomics using IPTL, iTRAQ, and TMT. | Q45841310 | ||
| Resistance to the Antiproliferative In Vitro Effect of PI3K-Akt-mTOR Inhibition in Primary Human Acute Myeloid Leukemia Cells Is Associated with Altered Cell Metabolism | Q48043104 | ||
| Patients with acute myeloid leukemia can be subclassified based on the constitutive cytokine release of the leukemic cells; the possible clinical relevance and the importance of cellular iron metabolism. | Q51102707 | ||
| Therapeutic targeting of leukemic stem cells in acute myeloid leukemia - the biological background for possible strategies. | Q51818965 | ||
| Stem cell gene expression programs influence clinical outcome in human leukemia. | Q51856192 | ||
| Mammalian target of rapamycin (mTOR) inhibition activates phosphatidylinositol 3-kinase/Akt by up-regulating insulin-like growth factor-1 receptor signaling in acute myeloid leukemia: rationale for therapeutic inhibition of both pathways. | Q53526869 | ||
| Expression profile of heat shock proteins in acute myeloid leukaemia patients reveals a distinct signature strongly associated with FLT3 mutation status--consequences and potentials for pharmacological intervention. | Q53769196 | ||
| Splenic tyrosine kinase (SYK) inhibitors and their possible use in acute myeloid leukemia. | Q54118068 | ||
| Two acute myeloid leukemia patient subsets are identified based on the constitutive PI3K-Akt-mTOR signaling of their leukemic cells; a functional, proteomic and transcriptomic comparison. | Q54976555 | ||
| IGF1 receptor signaling pathways. | Q54982190 | ||
| The IGF2/IGF1R/Nanog Signaling Pathway Regulates the Proliferation of Acute Myeloid Leukemia Stem Cells. | Q55709078 | ||
| Secretion of IL-2, IL-3, IL-4, IL-6 and GM-CSF by CD4+ and CD8+ TCR alpha beta+ T-cell clones derived early after allogeneic bone marrow transplantation | Q72822880 | ||
| In vitro effects of insulin-like growth factor-1 (IGF-1) on proliferation and constitutive cytokine secretion by acute myelogenous leukemia blasts | Q74630699 | ||
| Stress-induced in vitro apoptosis of native human acute myelogenous leukemia (AML) cells shows a wide variation between patients and is associated with low BCL-2:Bax ratio and low levels of heat shock protein 70 and 90 | Q83115248 | ||
| Impact of insulin-like growth factor 1 and insulin-like growth factor binding proteins on outcomes in acute myeloid leukemia | Q86861698 | ||
| Downregulation of monocarboxylate transporter 1 inhibits the invasion and migration through suppression of the PI3K/Akt signaling pathway in human nasopharyngeal carcinoma cells | Q89037283 | ||
| P921 | main subject | acute myeloid leukemia | Q264118 |
| P304 | page(s) | 20 | |
| P577 | publication date | 2019-06-19 | |
| P1433 | published in | Signal Transduction and Targeted Therapy | Q108821959 |
| P1476 | title | Effects of insulin and pathway inhibitors on the PI3K-Akt-mTOR phosphorylation profile in acute myeloid leukemia cells | |
| P478 | volume | 4 |
| Q90596650 | Cinobufotalin powerfully reversed EBV-miR-BART22-induced cisplatin resistance via stimulating MAP2K4 to antagonize non-muscle myosin heavy chain IIA/glycogen synthase 3β/β-catenin signaling pathway |
| Q93195711 | Enhancing the antitumor activity of an engineered TRAIL-coated oncolytic adenovirus for treating acute myeloid leukemia |
| Q90613895 | Increased mTOR activation in idiopathic multicentric Castleman disease |
| Q92705211 | Pathological Roles of Mitochondrial Oxidative Stress and Mitochondrial Dynamics in Cardiac Microvascular Ischemia/Reperfusion Injury |
| Q97533139 | SPEN induces miR-4652-3p to target HIPK2 in nasopharyngeal carcinoma |
| Q91975278 | The PI3K/AKT Pathway Inhibitor ISC-4 Induces Apoptosis and Inhibits Growth of Leukemia in Preclinical Models of Acute Myeloid Leukemia |
Search more.